H. Uramoto

H. Uramoto, M. Matoba, K. Usuda, 2017, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

The Prognostic Significance of HER 2 Overexpression in Non-small Cell Lung Cancer

F. Tanaka, H. Uramoto, M. Nakagawa, 2011 .

Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers

H. Uramoto, K. Usuda, N. Motono, 2018, AntiCancer Research.

Clinical significance of bifocal treatment for synchronous brain metastasis in T1-2 non-small-cell lung cancers: JNETS0301

A. Sakurada, H. Uramoto, S. Shiono, 2021, General Thoracic and Cardiovascular Surgery.

Depletion of WNT10A Prevents Tumor Growth by Suppressing Microvessels and Collagen Expression

Y. Sasaguri, H. Uramoto, H. Izumi, 2019, International journal of medical sciences.

Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.

F. Tanaka, T. Oyama, H. Uramoto, 2011, Anticancer Research.

Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence.

T. Oyama, H. Uramoto, K. Yasumoto, 2011, The Journal of thoracic and cardiovascular surgery.

Primary Pulmonary Angiosarcoma Presenting with Hemoptysis and Ground-Glass Opacity: A Case Report and Literature Review.

F. Tanaka, H. Uramoto, H. Mukae, 2015, The Tohoku journal of experimental medicine.

Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer.

M. Morita, T. Oyama, K. Sugio, 2005, Frontiers in bioscience : a journal and virtual library.

T790M is associated with a favorable prognosis in Japanese patients treated with an EGFR-TKI.

F. Tanaka, H. Uramoto, S. Yano, 2012, Lung cancer.

Is Overweight Related to the Prognosis of Octogenarians with Lung Cancer?

H. Uramoto, A. Yamagata, Shun Iwai, 2022, Obesity Surgery.

Prediction of recurrence after complete resection in patients with NSCLC.

F. Tanaka, H. Uramoto, 2012, Anticancer research.

Clinical significance of IGF1R expression in non-small-cell lung cancer.

F. Tanaka, H. Uramoto, M. Nakagawa, 2012, Clinical lung cancer.

Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung.

F. Tanaka, H. Uramoto, M. Nakagawa, 2011, Experimental and therapeutic medicine.

Pulmonary Function After Lobectomy: Video-Assisted Thoracoscopic Surgery Versus Muscle-Sparing Mini-thoracotomy

H. Uramoto, Makoto Tanaka, M. Sagawa, 2017, Indian Journal of Surgery.

The tumour shape of lung adenocarcinoma is related to the postoperative prognosis.

F. Tanaka, H. Uramoto, T. Baba, 2012, Interactive cardiovascular and thoracic surgery.

Surgical Treatment for Metachronous Lung Cancers

K. Sugio, H. Uramoto, K. Yasumoto, 2007 .

Clinical Usefulness of FDG-PET in the Diagnosis of Lung Cancer

K. Sugio, H. Uramoto, K. Yasumoto, 2006 .

Repeat pulmonary resection for lung malignancies does not affect the postoperative complications: a retrospective study

H. Uramoto, K. Usuda, Shun Iwai, 2021, BMC Pulmonary Medicine.

Pulmonary Resection for Metastatic Gastric Cancer.

H. Uramoto, Y. Iijima, H. Akiyama, 2016, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Expression of cytochrome P450 in non-small cell lung cancer.

Masaru Morita, Hidetaka Uramoto, M. Morita, 2008, Frontiers in bioscience : a journal and virtual library.

Dual outline of navigating utensil in thoracoscopic segmentectomy: a new method.

H. Uramoto, I. Mikami, T. Nishida, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma

F. Tanaka, H. Uramoto, M. Nakagawa, 2012, Tumor Biology.

A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer—Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study

A. Sakurada, Satomi Takahashi, H. Uramoto, 2020, Journal of thoracic disease.

Total Vertebrectomy for Non-Small Cell Lung Cancer

F. Tanaka, H. Uramoto, T. Kuwata, 2012, Case Reports in Oncology.

Three cases of false positive on FDG-PET in thoracic nodule

K. Sugio, H. Uramoto, K. Yasumoto, 2005 .

Clinicopathologic characteristics of non-small cell lung cancer in patients with smoking-related chronic obstructive pulmonary disease

H. Uramoto, M. Tomita, K. Usuda, 2018, General Thoracic and Cardiovascular Surgery.

What is the allowed volume threshold for chest tube removal after lobectomy: A randomized controlled trial

H. Uramoto, K. Usuda, Shun Iwai, 2019, Annals of medicine and surgery.

Virtual thoracoscopic imaging-assisted pleural marking of pulmonary nodules.

H. Uramoto, A. Yamagata, K. Usuda, 2020, Journal of thoracic disease.

Thoracoscopic small pulmonary nodule detection using computed tomography-guided cutaneous marking and pleural marking.

H. Uramoto, K. Usuda, Shun Iwai, 2019, Journal of thoracic disease.

TS expression predicts postoperative recurrence in adenocarcinoma of the lung.

H. Uramoto, M. Nakagawa, T. Hanagiri, 2011, Lung cancer.

Simple prophylactic fixation for lung torsion.

H. Uramoto, M. Takenoyama, T. Hanagiri, 2010, The Annals of thoracic surgery.

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

H. Uramoto, T. Hanagiri, H. Shimokawa, 2010, Anticancer research.

Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer‐related proteins

T. Oyama, K. Sugio, H. Uramoto, 2009, Cancer.

The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.

M. Morita, T. Oyama, K. Sugio, 2006, Cancer.

A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.

M. Morita, T. Oyama, K. Sugio, 2005, Lung cancer.

Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer

T. Oyama, H. Uramoto, K. Yasumoto, 2001, Thorax.

Prognostic factors before and after recurrence of resected non-small cell lung cancer.

F. Tanaka, H. Uramoto, T. Baba, 2012, Respiratory investigation.

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer

M. Nishimura, F. Tanaka, H. Uramoto, 2021, Oncoimmunology.

Successful treatment of lung adenocarcinoma in an 18-year-old man

H. Uramoto, K. Yasumoto, M. Takenoyama, 2011, General thoracic and cardiovascular surgery.

Synchronous bilateral bronchopulmonary typical carcinoid: A case report and clinical analysis at our institute

H. Uramoto, I. Mikami, Y. Iijima, 2016 .

Evaluation of Topoisomerase I/Topoisomerase IIct Status in Esophageal Cancer

H. Uramoto, M. Nakagawa, S. Oka, 2014 .

A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.

H. Uramoto, K. Yasumoto, T. Osaki, 2010, Anticancer research.

A resected case of lung adenocarcinoma difficult to distinguish from infectious lung disease based on the image course

H. Uramoto, K. Usuda, Shun Iwai, 2020, The Journal of the Japanese Association for Chest Surgery.

Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator

H. Uramoto, A. Yamagata, Shun Iwai, 2021, BMC Surgery.

The importance of determining surgical indications in cases of lung cancer and interstitial pneumonia with multiple intrapulmonary lymph nodes

H. Uramoto, H. Sakai, H. Akiyama, 2015, International journal of surgery case reports.

Is lung resection appropriate for late octogenarians? Surgical outcomes of patients aged ≥ 80 years with lung cancer

H. Uramoto, A. Yamagata, K. Usuda, 2021, Clinical and Translational Oncology.

Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.

F. Tanaka, H. Uramoto, T. Baba, 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Correlation Between HLA Alleles and EGFR Mutation in Japanese Patients with Adenocarcinoma of the Lung

H. Uramoto, K. Yasumoto, T. Baba, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.

T. Oyama, K. Sugio, H. Uramoto, 2006, Anticancer research.

Discrepancy between the Clinical Image and Pathological Findings of Non-Small Cell Lung Cancer Harboring an Epidermal Growth Factor Receptor Gene Mutation That Was Surgically Resected after Gefitinib Treatment

F. Tanaka, H. Uramoto, H. Mukae, 2014, Case Reports in Oncology.

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

S. Eschrich, F. Tanaka, H. Uramoto, 2016, PloS one.

Postoperative survival According to the Glasgow Prognostic Score in Patients with Resected Lung Adenocarcinoma

H. Uramoto, Makoto Tanaka, M. Sagawa, 2016, Asian Pacific journal of cancer prevention : APJCP.

EGFR-activating mutations are not present in breast tumors of Japanese patients.

H. Uramoto, T. Hanagiri, Y. Nagata, 2010, Anticancer research.

Angiogenesis of lung cancer utilizes existing blood vessels rather than developing new vessels using signals from carcinogenesis.

F. Tanaka, H. Uramoto, S. Yamada, 2013, Anticancer research.

Primary Adenoid Cystic Carcinoma of the Peripheral Lungs.

F. Tanaka, H. Uramoto, M. Nakagawa, 2015, Journal of UOEH.

Successful extirpation of thoracic pleural lipoma by single-port thoracoscopic surgery.

H. Uramoto, S. Oka, T. Hanagiri, 2011, Asian journal of surgery.

Repeat pulmonary resection for lung malignancies does not affect the postoperative complications: a retrospective study

H. Uramoto, K. Usuda, Shun Iwai, 2020, BMC Pulmonary Medicine.

Surgical resection for patients with mucinous bronchioloalveolar carcinoma.

H. Uramoto, K. Yasumoto, T. Baba, 2010, Asian journal of surgery.

Combined pulmonary fibrosis and emphysema predicts recurrence following surgery in patients with stage I non-small cell lung cancer

H. Uramoto, K. Usuda, N. Motono, 2018, Medical Oncology.

Six Cases of Lung Adenocarcinoma Successfully Treated Using Alternate Day Administration of Gefitinib

F. Tanaka, H. Uramoto, T. Kuwata, 2013 .

Lack of direct association between EGFR mutations and ER beta expression in lung cancer.

F. Tanaka, H. Uramoto, T. Onitsuka, 2011, Anticancer research.

The expression of CD146 predicts a poor overall survival in patients with adenocarcinoma of the lung.

F. Tanaka, H. Uramoto, S. Oka, 2012, Anticancer research.

Expression of Notch 1 and Numb in small cell lung cancer

M. Nishimura, M. Munakata, F. Tanaka, 2017 .

Sleeve lobectomy for patients with non-small cell lung cancer.

H. Uramoto, K. Yasumoto, T. Baba, 2010, International journal of surgery.

A case of thoracic aortic dissection that was difficult to differentiate from lung cancer or hemangiosarcoma

H. Uramoto, A. Yamagata, K. Usuda, 2020, The Journal of the Japanese Association for Chest Surgery.

Predictive factors related to pleural dissemination in non-small cell lung cancer

H. Uramoto, K. Usuda, Shun Iwai, 2020, Journal of thoracic disease.

Easy Diagnosis of Aortic Invasion in Patients with Lung Cancer Using Cine Magnetic Resonance Imaging

H. Uramoto, H. Akiyama, Y. Nakajima, 2015, Case Reports in Oncology.

Results of surgical resection for patients with thymoma according to World Health Organization histology and Masaoka staging.

F. Tanaka, H. Uramoto, M. Nakagawa, 2012, Asian journal of surgery.

Peroxiredoxin 4 improved aging-related delayed wound healing in mice.

H. Uramoto, Jianbo Zheng, S. Yamada, 2021, The Journal of investigative dermatology.

Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease

Y. Sasaguri, H. Uramoto, H. Izumi, 2016, PloS one.

Surgical Resection of Primary Lung Cancer with Exceptional Branch of V2 Terminalis by Three-dimensional Angiography—A Case Report and a Review of the Literature—

H. Uramoto, Y. Enomoto, Hiroyasu Kinoshita, 2016 .

Risk factors of chest wall invasion in non-small cell lung cancer

H. Uramoto, A. Yamagata, K. Usuda, 2021, Journal of thoracic disease.

Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer

H. Uramoto, K. Usuda, Shun Iwai, 2020, BMC Pulmonary Medicine.

Genomics of Tumor Origin and Characteristics for Adenocarcinoma and Malignant Pleural Mesothelioma: A Case Report

H. Uramoto, Y. Niida, A. Yamagata, 2022, Frontiers in Oncology.

Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region

H. Uramoto, Y. Nishino, S. Yano, 2021, Journal of Cancer Research and Clinical Oncology.

Neuroblastoma‐specific cytotoxicity mediated by the Mash1‐promoter and E. coli purine nucleoside phosphorylase

H. Uramoto, F. Watt, V. Sumantran, 2005, Pediatric blood & cancer.

Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer neovasculature

H. Uramoto, H. Izumi, K. Kohno, 2015, Clinical and Translational Oncology.

Reduced expression of catenin subtypes is a potential indicator of unfavorable prognosis in esophageal squamous cell carcinoma.

T. Oyama, K. Sugio, H. Uramoto, 2009, Molecular medicine reports.

Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma

H. Uramoto, K. Yasumoto, T. Baba, 2010, Cancer science.

Identification of a lung cancer antigen evading CTL attack due to loss of human leukocyte antigen (HLA) class I expression

H. Uramoto, K. Yasumoto, T. Baba, 2010, Cancer science.

Robotic resection of ectopic mediastinal parathyroid adenoma with intraoperative parathyroid hormone monitoring: a case report

H. Uramoto, A. Yamagata, Shun Iwai, 2022, Journal of Cardiothoracic Surgery.

A case of anaphylactic shock induced by TachoSil ® during surgery

H. Uramoto, Takuya Inoue, Yuki Owada, 2015 .

A case of intrathoracic beaded schwannomas originating from multiple intercostal nerves

H. Uramoto, K. Usuda, Shun Iwai, 2019, The Journal of the Japanese Association for Chest Surgery.

Clinical significance of human leukocyte antigen loss and melanoma-associated antigen 4 expression in smokers of non-small cell lung cancer patients

F. Tanaka, H. Uramoto, T. Baba, 2013, International Journal of Clinical Oncology.

Intrapleural chemotherapy improves the survival of non-small cell lung cancer patients with positive pleural lavage cytology

F. Tanaka, H. Uramoto, T. Baba, 2013, Surgery Today.

Surgical Treatment for Pulmonary Metastasis of Head and Neck Cancer: Study of 58 Cases.

H. Uramoto, Y. Iijima, H. Akiyama, 2017, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Video-assisted thoracoscopic pericardiectomy for malignant pericardial effusion.

H. Uramoto, T. Hanagiri, 2010, Anticancer research.

Invasive area to tumor ratio is a significant prognostic factor for non‐small cell lung cancer

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Thoracic cancer.

Adaptation criterion for segmentectomy in small‐sized early stage non‐small cell lung cancer

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Thoracic cancer.

Improvements in perioperative outcomes for non-small cell lung cancer: a decade-long analysis

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Surgical Endoscopy.

Role of indocyanine green in anomalous arterial supply to the normal dorsobasal segment of the lung

H. Uramoto, K. Usuda, Shun Iwai, 2022, Journal of Cardiothoracic Surgery.

Sternal resection and reconstruction for metastasis due to breast cancer: the Marlex sandwich technique and implantation of a pedicled latissimus dorsi musculocutaneous flap

H. Uramoto, N. Motono, T. Kamata, 2019, Journal of Cardiothoracic Surgery.

Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.

F. Tanaka, H. Uramoto, T. Baba, 2012, Interactive cardiovascular and thoracic surgery.

Hazardous environmental factors enhance impairment of liver function in HBV and HCV hepatitis.

T. Oyama, K. Sugio, H. Uramoto, 2009, Frontiers in bioscience.

Pulmonary resection for a foreign body in respiratory tract with severe aortic valve stenosis: A case report.

H. Uramoto, K. Usuda, Y. Iijima, 2022, Asian journal of surgery.

s of PTEN Expression by Blocking Nuclear Translocation GR1 in Gefitinib-Resistant Lung Cancer Cells Harboring

H. Uramoto, K. Yasumoto, Kazutaka Nakashima, 2010 .

Factors predicting the surgical outcome in patients with T3/4 lung cancer

F. Tanaka, H. Uramoto, Y. Ichiki, 2014, Surgery Today.

Critical in vivo roles of WNT10A in wound healing by regulating collagen expression/synthesis in WNT10A-deficient mice

Y. Sasaguri, H. Uramoto, H. Izumi, 2018, PloS one.

Quantitative evaluation of iodine and fat using dual-energy CT for assessments of the tumor aggressiveness in lung cancer

H. Uramoto, M. Matoba, H. Tonami, 2022, Egyptian Journal of Radiology and Nuclear Medicine.

Clinical outcomes and survival following placement of self‐expandable metallic stents for central airway stenosis and fistula

H. Uramoto, A. Yamagata, K. Usuda, 2020, Thoracic cancer.

Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity.

H. Uramoto, Y. Yoshida, H. Izumi, 2001, Nucleic acids research.

Hypotension due to Chemotherapy in a Patient with Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome Undergoing Hemodialysis: A First Case Report

F. Tanaka, H. Uramoto, T. Baba, 2012, Case Reports in Oncology.

Usefulness of intraoperative nerve monitoring for giant type AB thymoma combined with an aberrant right subclavian artery: a case report

H. Uramoto, A. Yamagata, Shun Iwai, 2022, Journal of Cardiothoracic Surgery.

Efficacy of direct oral anticoagulant for renal infarction due to pulmonary vein stump thrombosis after left pneumonectomy

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Surgical Case Reports.

Sclerosing mediastinitis of unknown origin: Report of a case

F. Tanaka, H. Uramoto, S. Yamada, 2015, International journal of surgery case reports.

Structural and functional characterization of two human V-ATPase subunit gene promoters.

H. Uramoto, Y. Yoshida, H. Izumi, 2003, Biochimica et biophysica acta.

Preoperative embolization followed by palliative therapy for patients unable to undergo the complete removal of a chronic expanding hematoma--a case report.

F. Tanaka, H. Uramoto, T. Kuwata, 2013, Asian journal of surgery.

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy.

H. Uramoto, Y. Yoshida, H. Izumi, 2003, Cancer treatment reviews.

Unusual local and distant metastases after complete resection of roentgenographically occult squamous cell carcinoma

H. Uramoto, A. Yamagata, K. Usuda, 2020, General Thoracic and Cardiovascular Surgery.

Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing

H. Uramoto, Y. Akagi, M. Kikuchi, 2017, International journal of oncology.

Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma

Atsushi Sekimura, Nozomu Motono, Katsuo Usuda, 2018, Medical Oncology.

Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations.

H. Uramoto, K. Yasumoto, Kazutaka Nakashima, 2010, Cancer research.

Localized malignant pleural mesothelioma arising in the interlobar fissure: a unique surgical case masquerading clinicopathologically as primary lung adenocarcinoma

Y. Sasaguri, H. Uramoto, K. Nabeshima, 2019, SAGE open medical case reports.

Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.

F. Tanaka, H. Uramoto, Yasuhiro Chikaishi, 2013, Lung cancer.

Differentiation between suture recurrence and suture granuloma after pulmonary resection for lung cancer by diffusion-weighted magnetic resonance imaging or FDG-PET / CT

H. Uramoto, M. Matoba, Y. Ueda, 2020, Translational oncology.

The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity

H. Uramoto, Y. Ishii, M. Sasahara, 2004, Experimental Neurology.

MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

R. Bernards, T. Knijnenburg, L. Wessels, 2012, Cell.

The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma

Y. Sasaguri, H. Uramoto, H. Izumi, 2014, British Journal of Cancer.

Long-term progress of six cases of malignant peripheral nerve sheath tumors of the mediastinum that underwent surgical treatment: Case report series

H. Uramoto, I. Mikami, Y. Iijima, 2016, International journal of surgery case reports.

Expression of Notch1 and Numb in small cell lung cancer

M. Nishimura, M. Munakata, F. Tanaka, 2017, Oncotarget.

p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression*

H. Uramoto, K. Yasumoto, H. Izumi, 2002, The Journal of Biological Chemistry.

Recurrence after surgery in patients with NSCLC.

Fumihiro Tanaka, Hidetaka Uramoto, F. Tanaka, 2014, Translational lung cancer research.

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking

T. Oyama, K. Sugio, H. Uramoto, 2006, British Journal of Cancer.

Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis

H. Uramoto, Y. Ishigaki, Yuka Nakamura, 2020, Oxidative medicine and cellular longevity.

Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling.

H. Uramoto, M. Kuwano, M. Ono, 2013, Cancer research.

Solitary lung metastasis from gestational choriocarcinoma resected six years after hydatidiform mole: A case report

H. Uramoto, I. Mikami, Y. Iijima, 2016, International journal of surgery case reports.

Molecular genetic tumor markers in non-small cell lung cancer.

M. Morita, T. Oyama, K. Sugio, 2005, Anticancer research.

The prognostic significance of HER2 overexpression in non-small cell lung cancer.

Fumihiro Tanaka, Hidetaka Uramoto, F. Tanaka, 2011, Anticancer research.

Müllerian cyst in posterior mediastinum: A report of a case

H. Uramoto, K. Usuda, Shun Iwai, 2018, International journal of surgery case reports.

[Intrapericardial Vessel Management for Lung Cancer Surgery].

F. Tanaka, H. Uramoto, Naoko Imanishi, 2015, Journal of UOEH.

Pulmonary Nodule and Mass: Superiority of MRI of Diffusion-Weighted Imaging and T2-Weighted Imaging to FDG-PET/CT

H. Uramoto, M. Matoba, Mariko Doai, 2021, Cancers.

Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses

H. Uramoto, M. Matoba, Mariko Doai, 2021, Cancers.

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.

T. Oyama, K. Sugio, H. Uramoto, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathologic characteristics of mucinous carcinoma of the breast.

H. Uramoto, K. Yasumoto, M. Takenoyama, 2010, International surgery.

Current Topics on Salvage Thoracic Surgery in Patients with Primary Lung Cancer.

H. Uramoto, 2016, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

A case of secondary pneumothorax due to pulmonary metastasis from epithelioid sarcoma of the vulva

H. Horinouchi, H. Uramoto, Takuya Inoue, 2015 .

Prognostic implications of human leukocyte antigen class I expression in patients who underwent surgical resection for non-small-cell lung cancer.

F. Tanaka, H. Uramoto, T. Baba, 2013, The Journal of surgical research.

Detection of EGFR and K-ras mutations for diagnosis of multiple lung adenocarcinomas.

T. Oyama, K. Sugio, H. Uramoto, 2011, Frontiers in bioscience.

Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma.

H. Uramoto, M. Kuwano, M. Ono, 2011, Lung cancer.

Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance.

M. Morita, T. Oyama, K. Sugio, 2005, Lung cancer.

[Chemotherapy for lung cancer patients].

H. Uramoto, J. Tsukada, S. Kagami, 2006, Journal of UOEH.

Malignant Melanoma of the Nipple: A Case Report

F. Tanaka, H. Uramoto, M. Yoshioka, 2018, Journal of breast cancer.

What is an appropriate material to use with a covering technique to prevent the recurrence of spontaneous pneumothorax?

F. Tanaka, H. Uramoto, 2014, Journal of Cardiothoracic Surgery.

What factors predict recurrence of a spontaneous pneumothorax?

F. Tanaka, H. Uramoto, H. Shimokawa, 2012, Journal of Cardiothoracic Surgery.

Natural air leak test without submergence for spontaneous pneumothorax

F. Tanaka, H. Uramoto, 2011, Journal of cardiothoracic surgery.

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer

H. Uramoto, Y. Ueda, K. Usuda, 2021, Clinical pathology.

A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity

A. Sakurada, H. Uramoto, S. Shiono, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation.

Y. Yatabe, T. Mitsudomi, F. Tanaka, 2014, Lung cancer.

Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.

T. Oyama, H. Uramoto, T. Hanagiri, 2010, Anticancer research.

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations.

T. Oyama, K. Sugio, H. Uramoto, 2009, Lung Cancer.

Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.

K. Sugio, H. Uramoto, K. Yasumoto, 2010, Lung cancer.

Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status

T. Oyama, H. Uramoto, K. Yasumoto, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Resistance to gefitinib

T. Oyama, K. Sugio, H. Uramoto, 2006, International Journal of Clinical Oncology.

Smoking cessation program and CYP2A6 polymorphism.

T. Oyama, K. Sugio, H. Uramoto, 2006, Frontiers in bioscience : a journal and virtual library.

The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer

L. Landi, A. D’Incecco, F. Cappuzzo, 2017, Science Signaling.

Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.

Fumihiro Tanaka, Tadaaki Yamada, Hidetaka Uramoto, 2012, Anticancer research.

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

J. Yokota, M. Oda, Y. Yatabe, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line

F. Tanaka, H. Uramoto, E. Hara, 2015, Cancer science.

Clinical Significance of Epithelial-Mesenchymal Transition-Associated Markers in Malignant Pleural Mesothelioma

F. Tanaka, H. Uramoto, K. Kohno, 2014, Oncology.

Diffusion-weighted magnetic resonance imaging is useful for the response evaluation of chemotherapy and/or radiotherapy to recurrent lesions of lung cancer

H. Uramoto, M. Matoba, Y. Ueda, 2019, Translational oncology.

Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?

T. Mitsudomi, H. Uramoto, H. Uramoto, 2007, British Journal of Cancer.

Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.

M. Morita, T. Oyama, K. Sugio, 2006, Lung cancer.

Epidermal Growth Factor Receptor-GEP100-Arf6 Axis Affects the Prognosis of Lung Adenocarcinoma

F. Tanaka, H. Uramoto, S. Yamada, 2014, Oncology.

The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.

Fumihiro Tanaka, Hidetaka Uramoto, F. Tanaka, 2011, Anticancer research.

The expression of Ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung.

Fumihiro Tanaka, Hidetaka Uramoto, F. Tanaka, 2011, Anticancer research.

A positive relationship between filamin and VEGF in patients with lung cancer.

H. Uramoto, L. Akyürek, T. Hanagiri, 2010, Anticancer research.

Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.

H. Uramoto, T. Hanagiri, K. Ono, 2010, Anticancer research.

A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR.

T. Oyama, K. Sugio, H. Uramoto, 2007, Anticancer research.

Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment

T. Ishizuka, H. Uramoto, M. Kawasaki, 2020, Journal of clinical medicine.

What is the best drug as a front-line treatment for EGFR activating mutation?

H. Uramoto, 2018, Precision Cancer Medicine.

Indocyanine green fluorescence-guided thoracoscopic pulmonary resection for intralobar pulmonary sequestration: a case report

H. Uramoto, K. Usuda, Shun Iwai, 2019, Journal of Medical Case Reports.

Low-dose indocyanine green fluorescence-navigated segmentectomy: prospective analysis of 20 cases and review of previous reports.

H. Uramoto, K. Usuda, Shun Iwai, 2019, Journal of thoracic disease.

Congenital partial pericardial defect discovered incidentally during surgery for lung cancer: a case report and literature review

H. Uramoto, A. Yamagata, Shun Iwai, 2021, BMC Surgery.

[Management of patients with bronchial foreign bodies].

F. Tanaka, H. Uramoto, T. Baba, 2011, Journal of UOEH.

The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma

Y. Sasaguri, H. Uramoto, H. Izumi, 2014, Tumor Biology.

Surgical treatment of patients with stenosis of the central airway due to tracheal tumours.

H. Uramoto, K. Yasumoto, M. Takenoyama, 2010, Asian journal of surgery.

Successful endovascular coil embolization in an elder and asymptomatic case of anomalous systemic arterial supply to the normal basal segment

H. Uramoto, Y. Machida, K. Usuda, 2017, International journal of surgery case reports.

A case of thymic cyst in the middle mediastinum

H. Uramoto, Hiroyuki Suzuki, Y. Iijima, 2016 .

A case of left lower lobectomy with PLSVC (persistent left superior vena cava)

H. Uramoto, Y. Minamiya, Maiko Atari, 2016 .

A case of resection in which lung cancer complicated by partial anomalous pulmonary venous connection was detected preoperatively

H. Uramoto, Hiroyuki Suzuki, Y. Iijima, 2016 .

A rare case of lung cancer associated with the azygos lobe: A case report and literature review

H. Uramoto, Y. Iijima, H. Akiyama, 2016 .

Anterior mediastinal ectopic pancreatic cyst incidentally identified by pericarditis: a case report

H. Uramoto, A. Yamagata, K. Usuda, 2020, General Thoracic and Cardiovascular Surgery.

Surgical resection of tracheal carinal leiomyoma: Report of a case

H. Uramoto, M. Takenoyama, S. Oka, 2011 .

An endobronchial lipoma successfully resected by high-frequency electric snare: a report of 2 cases.

F. Tanaka, H. Uramoto, M. Nakagawa, 2012, Journal of bronchology & interventional pulmonology.

Two Cases of Single-Stage Closure of a Bronchopleural Fistula Using Latissimus Dorsi Musculocutaneous Flaps after Lung Surgery.

H. Uramoto, Takuya Inoue, H. Akiyama, 2015, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Vacuolar H+-ATPase: functional mechanisms and potential as a target for cancer chemotherapy

H. Uramoto, Y. Yoshida, H. Izumi, 2002, Anti-cancer drugs.

An extremely rare case report of surgery of lung cancer with the absence of azygos vein

H. Uramoto, Y. Minamiya, Y. Iijima, 2016, Surgical and Radiologic Anatomy.

The development of bronchopleural fistula in lung cancer patients after major surgery: 31 years of experience with 19 cases.

H. Uramoto, T. Hanagiri, 2011, Anticancer research.

An alternative posterior ascending pulmonary artery treatment in lobectomy with inflammatory lymph node infiltration

H. Uramoto, A. Yamagata, Shun Iwai, 2022, Journal of Cardiothoracic Surgery.

Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.

F. Tanaka, H. Uramoto, K. Yasumoto, 2011, Lung cancer.

Hypoxia-induced and calpain-dependent cleavage of filamin A regulates the hypoxic response

J. Borén, H. Uramoto, L. Poellinger, 2014, Proceedings of the National Academy of Sciences.

Cancer stem cell markers in lung cancer

F. Tanaka, T. Oyama, H. Uramoto, 2015 .

Dysregulation of Platelet-Derived Growth Factor β-Receptor Expression by ΔNp73 in Neuroblastoma

H. Uramoto, A. Nakagawara, T. Ozaki, 2009, Molecular Cancer Research.

Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC.

T. Oyama, H. Uramoto, K. Yasumoto, 2010, Lung cancer.

pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF β-receptor transcription

H. Uramoto, H. Izumi, K. Funa, 2004, Journal of Cell Science.

Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA.

H. Uramoto, H. Itoh, Y. Yoshida, 2002, Biochemical and biophysical research communications.

The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma

H. Uramoto, N. Kurose, Jianbo Zheng, 2019, International journal of medical sciences.

The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.

H. Uramoto, T. Homma, J. Fujii, 2019, Antioxidants & redox signaling.

Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells

Y. Sasaguri, T. Oyama, H. Uramoto, 2011, Cancer science.

Phase II trial of carboplatin/docetaxel in patients with resected NSCLC

F. Tanaka, H. Uramoto, A. Uchiyama, 2014 .

Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.

F. Tanaka, H. Uramoto, S. Yamada, 2013, Clinical lung cancer.

Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer

F. Tanaka, H. Uramoto, S. Oka, 2011, Journal of cardiothoracic surgery.

Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer.

H. Uramoto, K. Yasumoto, A. Uchiyama, 2005, Anticancer research.

Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection

Y. Sasaguri, H. Uramoto, K. Kohno, 2016, Oncotarget.

Results of surgical resection for patients with large cell carcinoma of the lung.

H. Uramoto, K. Yasumoto, T. Baba, 2010, International journal of surgery.

Case report of surgical treatment of scoliosis caused by neurofibroma located posterior mediastinum

H. Uramoto, N. Kawahara, N. Motono, 2018, International journal of surgery case reports.

Long-term survivor of primary anorectal malignant melanoma by a multi-disciplinary approach.

H. Uramoto, T. Nagaie, T. Yamashita, 2011, Asian journal of surgery.

Basaloid carcinoma of the lung associated with central cavitation: a unique surgical case focusing on cytological and immunohistochemical findings

Y. Sasaguri, H. Uramoto, T. Baba, 2012, Diagnostic Pathology.

Complete Resection of Thymic Sarcomatoid Carcinoma Through Total Aortic Arch Replacement.

F. Tanaka, H. Uramoto, A. Taira, 2016, The Annals of thoracic surgery.

Pulmonary basaloid carcinoma with cavity formation: A case report

H. Uramoto, T. Baba, M. Takenoyama, 2011 .

FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors

H. Uramoto, M. Matoba, Y. Ueda, 2018, Medical Oncology.

The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma

H. Uramoto, Y. Ikeda, N. Kurose, 2018, International journal of medical sciences.

Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes.

F. Tanaka, H. Uramoto, K. Yasumoto, 2012, Oncology letters.

Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.

H. Uramoto, T. Baba, S. Yamada, 2013, Anticancer research.

A case of G-CSF-producing lung squamous cell carcinoma showing recurrence after complete resection

H. Uramoto, Takuya Inoue, S. Yamada, 2015 .

Clinicopathologic significance of an immunohistochemical expression of p27 in scirrhous carcinoma of the breast

T. Oyama, K. Sugio, H. Uramoto, 2007, Breast cancer.

Basal Cell Adenocarcinoma of the Sublingual Gland: A Case of an Inadequate FNA Cytology Specimen Rendering Conclusive Diagnosis Difficult

H. Uramoto, T. Nakayama, S. Yamada, 2014 .

ASK1 Inhibits Astroglial Development via p38 Mitogen-Activated Protein Kinase and Promotes Neuronal Differentiation in Adult Hippocampus-Derived Progenitor Cells

H. Uramoto, M. Elmi, K. Funa, 2004, Molecular and Cellular Biology.

Hippocampus-Derived Progenitor Cells Promotes Neuronal Differentiation in Adult p 38 Mitogen-Activated Protein Kinase and ASK 1 Inhibits Astroglial Development via

H. Uramoto, M. Elmi, K. Funa, 2003 .

Multiple pleural nodules diagnosed as IgG4-related disease: a case report

H. Uramoto, K. Usuda, Shun Iwai, 2021, Surgical Case Reports.

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

H. Uramoto, K. Yasumoto, H. Izumi, 2003, The Biochemical journal.

Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan.

H. Uramoto, J. Tsukada, S. Kagami, 2007, Anticancer research.

[Clinical analysis of esophageal cancer associated with other primary cancers].

H. Uramoto, K. Yasumoto, T. Baba, 2011, Kyobu geka. The Japanese journal of thoracic surgery.

Detection of Mediastinal Lymph Node Metastases Using Indocyanine Green (ICG) Fluorescence Imaging in an Orthotopic Implantation Model

H. Uramoto, K. Kondo, Shilei Zhao, 2020, AntiCancer Research.

Advanced cadaver‐based educational seminar for trauma surgery using saturated salt solution‐embalmed cadavers

H. Uramoto, Shiei Kim, K. Mashiko, 2019, Acute medicine & surgery.

Identification of a tumour associated antigen in lung cancer patients with asbestos exposure.

Manabu Yasuda, Hidetaka Uramoto, H. Uramoto, 2010, Anticancer research.

Atmospheric temperature and pressure influence the onset of spontaneous pneumothorax

H. Uramoto, Makoto Tanaka, R. Honda, 2018, The clinical respiratory journal.

Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).

M. Nishimura, M. Munakata, F. Tanaka, 2015, Lung cancer.

170 Quality of Life for Patients Receiving Cancer Chemotherapy: The Japanese Perspective

H. Uramoto, J. Tsukada, 2010 .

Successful Multidisciplinary Treatment for Aggressive Primary Pulmonary Undifferentiated Pleomorphic Sarcoma

H. Uramoto, H. Hojo, M. Higuchi, 2020, Case Reports in Oncology.

Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses

H. Uramoto, M. Matoba, Mariko Doai, 2021, Cancers.

How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio

H. Uramoto, M. Matoba, Mariko Doai, 2021, Clinical Medicine Insights. Oncology.

Relationships and Qualitative Evaluation between Diffusion-Weighted Imaging and Pathologic Findings of Resected Lung Cancers

H. Uramoto, M. Matoba, Y. Ueda, 2020, Cancers.

Oncotargets and Therapy Dovepress Expression and Prognostic Value of Galnac-t3 in Patients with Completely Resected Small (#2 Cm) Peripheral Lung Adenocarcinoma after Iaslc/ats/ Ers Classification

T. Guo, H. Uramoto, Shilei Zhao, 2022 .

Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma

Y. Sasaguri, H. Uramoto, H. Izumi, 2015, Tumor Biology.

Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung.

H. Uramoto, S. Yamada, T. Hanagiri, 2010, Anticancer research.

Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer

H. Uramoto, S. Yamada, T. Hanagiri, 2010, Journal of cardiothoracic surgery.

Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer

H. Uramoto, K. Yasumoto, T. Baba, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges.

J. Borén, H. Uramoto, C. Beck, 2004, Current gene therapy.

Prognostic significance of histologic subtype in pStage I lung adenocarcinoma

H. Uramoto, Y. Machida, K. Usuda, 2017, Medical Oncology.

A case of schwannoma showing rapid growth

H. Uramoto, S. Yamada, H. Akiyama, 2016 .

New additional scoring formula on the Pathological Features in Stage I Lung Adenocarcinoma Patients: Impact on Survival

T. Guo, H. Uramoto, Shilei Zhao, 2020, International journal of medical sciences.

Expression of the p53 family in lung cancer.

T. Oyama, K. Sugio, H. Uramoto, 2006, Anticancer research.

Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury

Yuka Nakamura, Jing Zhang, Taiji Hamada, 2018, International journal of molecular sciences.

p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF β-receptor

H. Uramoto, K. Funa, Y. Matsumoto, 2004, Journal of Cell Science.

The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.

Y. Sasaguri, H. Uramoto, H. Izumi, 2015, Histology and histopathology.

Esophageal bypass using a gastric tube for a malignant tracheoesophageal/bronchoesophageal fistula: a report of 4 cases.

M. Morita, F. Tanaka, H. Uramoto, 2011, International surgery.

Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction

H. Uramoto, H. Izumi, K. Kohno, 2014, Journal of Experimental & Clinical Cancer Research.

13019Tension pyopneumothorax caused by Parvimonas micra: a case report

H. Uramoto, Shun Iwai, Y. Iijima, 2023, Journal of Cardiothoracic Surgery.

The 30-day mortality and hospital mortality after chest surgery described in the annual reports published by the Japanese Association for Thoracic and Cardiovascular Surgery

F. Tanaka, H. Uramoto, M. Okumura, 2015, General Thoracic and Cardiovascular Surgery.

Abnormal branch of right pulmonary artery (A7): a case report and literature review

H. Uramoto, Y. Minamiya, Y. Iijima, 2016, Surgical Case Reports.

A rare case of ipsilateral multiple sclerosing hemangioma with protrusion of segmental bronchus in young male patient

H. Uramoto, I. Mikami, Y. Iijima, 2016 .

Equivalent Outcome of Patients with Locally Advanced NSCLC Treated with Salvage Surgery Compared to Induction Chemotherapy Followed by Surgical Resection.

H. Uramoto, H. Akiyama, Y. Nakajima, 2016, Anticancer research.

Intraoperative ultrasound elastography has little diagnostic benefit for deeper tumours of the lung.

H. Uramoto, Y. Nakajima, Hiroyasu Kinoshita, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Possibility of determining the degree of adhesion of the lymph node to the pulmonary artery preoperatively

H. Uramoto, Y. Nakajima, Hiroyasu Kinoshita, 2015, Journal of Cardiothoracic Surgery.

Cytochrome P450 in non-small cell lung cancer related to exogenous chemical metabolism.

F. Tanaka, T. Oyama, H. Uramoto, 2012, Frontiers in bioscience.

Expression of Cytochrome P 450 in non-small cell lung cancer

M. Morita, A. Matsumoto, T. Oyama, 2008 .

Clinical Relevance of TAp73 and &Dgr;Np73 Protein Expression in Ovarian Cancer: A Series of 83 Cases and Review of the Literature

R. Zeillinger, H. Uramoto, H. Ulmer, 2011, International Journal of Gynecological Pathology.

Expression of ΔNp73 Predicts Poor Prognosis in Lung Cancer

M. Morita, T. Oyama, K. Sugio, 2004, Clinical Cancer Research.

Case report of two patients having successful surgery for lung cancer after treatment for Grade 2 radiation pneumonitis

H. Uramoto, H. Sakai, Yoshihiro Saito, 2015, Annals of medicine and surgery.

The Long-Term Outcomes of Induction Chemoradiotherapy Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer

H. Uramoto, Kunihiko Kobayashi, Takuya Inoue, 2014, Case Reports in Oncology.

Resection of chemo-refractory mediastinal yolk sac tumor: A case report

F. Tanaka, H. Uramoto, S. Shinohara, 2015 .

Temporal trends in the surgical outcomes of patients with breast cancer

F. Tanaka, H. Uramoto, M. Nakagawa, 2012, World Journal of Surgical Oncology.

Gender Difference as a Prognostic Factor in Patients Undergoing Resection of Non-Small Cell Lung Cancer

K. Sugio, H. Uramoto, K. Yasumoto, 2007, Surgery Today.

Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer.

M. Morita, Y. Kakeji, T. Oyama, 2005, Frontiers in bioscience : a journal and virtual library.

Apocrine carcinoma of the breast.

F. Tanaka, H. Uramoto, T. Baba, 2011, Journal of UOEH.

Immunohistochemical Expression and Serum Levels of CD44 as Prognostic Indicators in Patients with Non-Small Cell Lung Cancer

F. Tanaka, H. Uramoto, A. Taira, 2016, Oncology.

PRDX4 Improved Aging-Related Delayed Wound Healing in Mice

H. Uramoto, Jianbo Zheng, S. Yamada, 2022 .

Expression of aromatase CYP19 and its relationship with parameters in NSCLC.

N. Harada, T. Oyama, K. Sugio, 2009, Frontiers in bioscience.

Prediction of emergency hospitalization of outpatients receiving cancer chemotherapy.

H. Uramoto, J. Tsukada, S. Kagami, 2007, Anticancer research.

Individualization of risk factors for postoperative complication after lung cancer surgery: a retrospective study

H. Uramoto, K. Usuda, Shun Iwai, 2021, BMC Surgery.

Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer.

T. Yamanaka, M. Okada, Y. Nishimura, 2018, The Annals of thoracic surgery.

Isolated solitary lung metastasis 12 years after radical prostatectomy for prostate cancer without elevation of the serum prostate-specific antigen level

H. Uramoto, Y. Iijima, H. Akiyama, 2017 .

Interstitial Lung Disease and Partial Resection Are Poor Prognostic Factors for pStage IA NSCLC: a Retrospective Study

H. Uramoto, A. Yamagata, Shun Iwai, 2021 .

Cardiac arrest during lung cancer surgery: A report of four cases

H. Uramoto, A. Yamagata, K. Usuda, 2021, The Journal of the Japanese Association for Chest Surgery.

Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis.

T. Oyama, K. Sugio, H. Uramoto, 2007, Frontiers in bioscience : a journal and virtual library.

Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study.

H. Uramoto, Y. Nishino, S. Yano, 2022, Clinical lung cancer.

Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma

H. Uramoto, Shilei Zhao, C. Gu, 2021, International journal of medical sciences.

Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.

H. Uramoto, K. Yasumoto, N. Nose, 2011, Lung cancer.

Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction

H. Uramoto, H. Izumi, K. Kohno, 2014, Journal of experimental & clinical cancer research : CR.

Salvage thoracic surgery in patients with primary lung cancer.

F. Tanaka, H. Uramoto, 2014, Lung cancer.

Is extrathoracic metastasis screening necessary for clinical stage IA non-small cell lung cancer?

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Science progress.

Pleural dissemination of a mixed ground-glass opacity nodule treated as a nontuberculous mycobacterial infection for 6 years without growing remarkably.

F. Tanaka, H. Uramoto, Naoko Imanishi, 2015, Journal of thoracic disease.

Lung cancer combined with methotrexate-associated lymphoproliferative disorder: A case report

H. Uramoto, K. Usuda, Shun Iwai, 2019, International journal of surgery case reports.

Delta Np73 expression in thyroid neoplasms originating from follicular cells

H. Uramoto, A. Miyauchi, Yasuhiro Ito, 2006, Pathology.

Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never‐smoker women with pulmonary adenocarcinoma

F. Tanaka, H. Uramoto, 2013, Cancer.

Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report

H. Uramoto, Y. Ueda, K. Usuda, 2020, Annals of Medicine and Surgery.

PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Lung.

Early-stage multi-differentiated gastric carcinosarcoma and post-resection local recurrence: a case report

H. Uramoto, T. Kosaka, N. Kurose, 2020, Diagnostic Pathology.

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker

M. Nishimura, M. Munakata, F. Tanaka, 2016, OncoTarget.

Expression of deltaNp63 in squamous cell carcinoma of the esophagus.

M. Morita, T. Oyama, K. Sugio, 2005, Anticancer research.

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial

T. Ishizuka, H. Uramoto, M. Kawasaki, 2019, The oncologist.

Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival

M. Nishimura, F. Tanaka, H. Uramoto, 2020, Heliyon.

Limited pulmonary resection for peripheral small-sized adenocarcinoma of the lung.

H. Uramoto, K. Yasumoto, T. Baba, 2011, International journal of surgery.

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

F. Tanaka, H. Uramoto, A. Takamori, 2021, Cancer medicine.

Total vertebrectomy (Th2) and dissection of the subclavian artery for a superior sulcus tumor invading the spine: A case report

F. Tanaka, H. Uramoto, Naoko Imanishi, 2016, International journal of surgery case reports.

Indocyanine green fluorescence detects the blood flow of the bronchial anastomosis for bronchoplasty “case report”

H. Uramoto, N. Motono, 2020, Annals of medicine and surgery.

ICG easily detects not only the segmental plane, but also the course and blood distribution of the bronchial artery“case report”

H. Uramoto, N. Motono, 2018, Annals of medicine and surgery.

Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion

Katsuo Usuda, Hidetaka Uramoto, H. Uramoto, 2017, PloS one.

A prospective phase II study of gefitinib in non-small cell cancer patients with epidermal growth factor receptor gene (EGFR) mutations

T. Oyama, K. Sugio, H. Uramoto, 2007 .

Delayed Hemothorax after a Blunt Trauma—A Case Report—

H. Uramoto, A. Sekimura, 2018 .

Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.

Y. Korogi, H. Uramoto, T. Aoki, 2012, Radiology.

Improvements in perioperative outcomes for non-small cell lung cancer: a decade-long analysis

H. Uramoto, Shun Iwai, Y. Iijima, 2022, Surgical Endoscopy.

Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial Infection

H. Uramoto, M. Matoba, Mariko Doai, 2021, Cancers.

Pleomorphic carcinoma: report of a case with massive pleural effusion and asbestos particles.

T. Oyama, K. Sugio, H. Uramoto, 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.

S. Ieiri, H. Uramoto, H. Okajima, 2020, American journal of translational research.

A case of primary myoepithelial carcinoma of lung that was difficult to diagnose preoperatively

H. Uramoto, Y. Machida, K. Usuda, 2017 .

Expression of DeltaNp 63 in Squamous Cell Carcinoma of the Esophagus

M. Morita, T. Oyama, K. Sugio, 2009 .

Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study

H. Uramoto, Y. Nishino, S. Yano, 2023, BMC Pulmonary Medicine.

Results of Surgical Treatment for Patients with Small Cell Lung Cancer

K. Sugio, H. Uramoto, K. Yasumoto, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer

H. Uramoto, Shun Iwai, Y. Iijima, 2023, Oncology.

Two Resected Cases of Collision Cancer of the Lung

H. Uramoto, K. Yasumoto, M. Takenoyama, 2010 .

Results of a surgical resection for patients with stage IV non--small-cell lung cancer.

F. Tanaka, H. Uramoto, S. Oka, 2012, Clinical lung cancer.

Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.

H. Uramoto, Keiko Funa, 2003, Acta biochimica Polonica.

The Postoperative Complication After Lung Cancer Surgery Does Not Affect for Survival: A Retrospective Study

H. Uramoto, K. Usuda, Shun Iwai, 2021 .

Correlation Between HLA Alleles and EGFR Mutation in Japanese Patients with Adenocarcinoma of the Lung

H. Uramoto, K. Yasumoto, T. Baba, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion

F. Tanaka, H. Uramoto, M. Nakagawa, 2014, Indian Journal of Surgery.

Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.

H. Uramoto, M. Matoba, K. Usuda, 2017, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines

F. Tanaka, H. Uramoto, T. Aoki, 2014, Radiology and oncology.

Clinicopathologic Characteristics and Prognosis of Patients With Non–Small Cell Lung Cancer Who Undergo Pulmonary Segmentectomy

H. Uramoto, A. Taira, S. Oka, 2019, International surgery.

Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis.

M. Morita, T. Oyama, K. Sugio, 2006, Anticancer research.

International Journal of Surgery Case Reports Solitary Lung Metastasis from Gestational Choriocarcinoma Resected Six Years after Hydatidiform Mole: a Case Report

H. Uramoto, I. Mikami, H. Akiyama, 2022 .

The consecutive impact of COVID-19 on thoracic surgical procedures in Japan: an analysis of data from the National Clinical Database.

T. Hibi, H. Uramoto, Y. Hoshikawa, 2023, Surgery today.

Prognostic Significance of Lymphovascular Invasion for Patients with Stage I Non-Small Cell Lung Cancer

F. Tanaka, H. Uramoto, S. Yamada, 2011, European Surgical Research.